Steris

STE · NYSE · USD

$208.54Change from previous close: −0.38%Absolute change: −$0.80

Close · October 2, 2026

At a glance

Revenue growth
+8.73%
FY to Mar 2026 vs FY to Mar 2025
Net income growth
+27.27%
FY to Mar 2026 vs FY to Mar 2025
Net margin
13.2%
FY to Mar 2025: 11.3%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Total revenue1,4931,5881,4961,4601,391—
Cost of revenue809891841814763—
Gross profit684697656646628—
Selling, general and administrative370352352350354—
Research and development28.628.829.528.226.4—
Operating income286317274268248—
EBIT289320273268248—
EBITDA413443395390367—
Interest expense15.815.114.914.915.9—
Pre-tax income274305258253232—
Income tax72.584.263.560.653.9—
Net income200220193192177—
Net income to common shareholders200220193192177—
Basic EPS2.052.251.961.951.79—
Diluted EPS2.042.241.961.941.79—
Average shares (basic)97.698.098.298.498.4—
Average shares (diluted)97.998.498.698.898.8—